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ttp://dx.doi.org/10.1016/j.ajpath.2014.09.014Prostatic intraepithelial neoplasia is a precursor to prostate cancer. Herein, deletion of the NADþ-dependent
histone deacetylase Sirt1 induced histological features of prostatic intraepithelial neoplasia at 7 months of
age; these features were associated with increased cell proliferation and enhanced mitophagy. In human
prostate cancer, lower Sirt1 expression in the luminal epithelium was associated with poor prognosis. Ge-
netic deletion of Sirt1 increased mitochondrial superoxide dismutase 2 (Sod2) acetylation of lysine residue
68, thereby enhancing reactive oxygen species (ROS) production and reducing SOD2 activity. The PARK2
gene, which has several features of a tumor suppressor, encodes an E3 ubiquitin ligase that participates in
removal of damaged mitochondria via mitophagy. Increased ROS in Sirt1/ cells enhanced the recruitment
of Park2 to the mitochondria, inducing mitophagy. Sirt1 restoration inhibited PARK2 translocation and ROS
production requiring the Sirt1 catalytic domain. Thus, the NADþ-dependent inhibition of SOD2 activity and
ROS by SIRT1 provides a gatekeeper function to reduce PARK2-mediated mitophagy and aberrant cell sur-
vival. (Am J Pathol 2015, 185: 266e279; http://dx.doi.org/10.1016/j.ajpath.2014.09.014)Supported in part by NIH grants R01CA70896, R01CA75503, and
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Manchester, UK.The sirtuin family is a highly conserved group of NADþ-
dependent histone deacetylases.1,2 The SIRT1 human
homologue of the yeast Saccharomyces cerevisiae, the
Sir2 gene, regulates co-activators (p300/calcium-binding
protein),3 transcription factors [androgen receptor (AR)
and forkhead box O], and components of the cell cycle,
including the retinoblastoma protein.4e6 The effect of
SIRT1 on cell proliferation varies with cell type and
physiological conditions. SIRT1 promotes cell prolifera-
tion in colon, breast, and lung cancer cells and in tissue
culture.5,7,8 In contrast, SIRT1 inhibits prostate cancer
(PCa) cell proliferation and tumor growth and inhibits
expression and activity of the AR.9 In the prostate of
Sirt1/ mice, cellular proliferation was enhanced, asso-
ciated with altered expression of androgen-responsive
genes and histological feature of prostatic intraepithelial
neoplasia (PIN).10stigative Pathology.
.The onset and progression of human PCa involve a series
of distinct molecular genetic events.11 An understanding of
the molecular mechanisms governing PCa is important
because PCa remains the second leading cause of cancer
death in the United States, with approximately 190,000 new
SIRT1 Governs SOD2, PARK2, and Mitophagycases diagnosed and 27,000 deaths occurring annually.12
The morphological features of PCa progression involve
changes from PIN to invasive adenocarcinoma and metas-
tases.11 Deletion of Pten, forced expression of Myc, Nkx3-1,
and loss of Akt1 in transgenic mice are associated with
PIN.13,14 Histological markers of PIN include increased
expression of TP63 and a-methylacyl-CoA racemase
(AMACR). TP63, which encodes a homologue of the TP53
gene, is highly expressed in the basal prostate cell in normal
glands and PIN. The AMACR gene encodes a luminal marker
protein that is overexpressed in prostate carcinoma.15,16 The
combination of TP63 and AMACR is useful for diagnosing
PIN and early adenocarcinoma.
Cellular proliferation in prostate epithelial cells is a
dynamic equilibrium of proliferation, apoptosis, and macro-
autophagy. Macroautophagy is an evolutionarily conserved
catabolic process, requiring the formation of autophago-
somes that engulf macromolecules and organelles within a
cell. Autophagy is dynamically regulated by nutrient depri-
vation and cellular stress, including reactive oxygen species
(ROS), and is thought to play a role in diverse functions and
diseases, including aging, neurodegeneration, and tumor-
igenesis.17e19 A prosurvival function of autophagy aids in
the clearing of damaged proteins, aggregates, or organelles,
and it provides a cell with energy and anabolic building
blocks.20,21 Alternatively, autophagy may be a mechanism of
caspase- and apoptosis-independent cell death.22,23 The role
of autophagy in tumor onset and progression is complex,
with evidence for both tumor suppression and therapeutic
resistance, depending on the type and stage of the tumor.24,25
Pancreatic cancer requires autophagy for tumor growth.26 In
contrast, several studies demonstrated that autophagy con-
tributes to tumor cell killing by exogenous agents.27,28
Increased BECN1 abundance, an inducer of autophagy,
correlates with autophagy, and BECN1 haploinsufﬁciency
functions as a tumor-suppressor gene.25
Herein, we show direct evidence that Sirt1 inhibits PIN
in vivo using Sirt1/ mice. We show Sirt1 inhibits ROS via
deacetylation and activation of mitochondrial superoxide
dismutase 2 (Sod2), thereby reducing Park2 recruitment and
autophagy. We propose that SIRT1 functions as a tumor
suppressor in the prostate by inhibiting ROS and maintaining
the physiological status of the autophagy/mitophagy process.
Materials and Methods
Transgenic Mice and Genotyping
Sirt1 transgenic mice were provided by an author (M.W.M.)
and have been previously described.10 The appropriate insti-
tutional committeeeapproved protocols were followed when
working with these mice. To conﬁrm the genotype of the mice,
a PCR analysis was conducted on extracted tail DNA using an
oligonucleotide pair directed toward exon 5 of Sirt1 and a
single Pgk1 cassette primer speciﬁc for the knockout allele,
generating a Sirt1 endogenous amplimer of 423 bp and aThe American Journal of Pathology - ajp.amjpathol.orgSirt1-Pgk1 knockout vector amplimer of 526 bp [nucleotide
sequences, 50-TTCACATTGCATGTGTGTGG-30 (forward)
and 50-TAGCCTGCGTAGTGTTGGTG-30 (reverse); and
Pgk1, 50-ATTTGGTAGGGACCCAAAGG-30 (reverse)],
respectively.10
Gross Anatomical Analysis and IHC
Sirt1þ/þ and Sirt1/ mice, aged 3 and 7 months, were
euthanized by CO2 asphyxiation. Animals were dissected, with
the following organs being removed: ventrodorsolateral (VDL)
prostate and anterior prostate (AP) for hematoxylin and eosin
(H&E) and immunohistochemical (IHC) staining. Portions of
each organ were ﬁxed in 4% paraformaldehyde to be used for
generating sections.H&Estainingwasconductedalongwith IHC
staining. The following were used: AMACR (catalog number
107916; Santa Cruz Biotechnology, Dallas, TX), Ki-67 (catalog
number M7240; Dako, Carpinteria, CA), BECN1 (catalog
number 11427; SantaCruzBiotechnology),Nip3-like proteinX
(BNIP3L; catalog number ab8399; Abcam, Cambridge, MA),
light chain (LC)-3 (symbol Map1lc3a; catalog number 4108S;
Cell Signaling, Danvers, MA), SOD2-AcK68 [provided by Dr.
David Gius29 (Northwestern University, Chicago, IL)], and
phospho-50-adenosine monophosphate-activated protein kinase
(pAMPK) (catalog number 2531S; Cell Signaling).
Parafﬁn Embedding and Tissue Sectioning
Paraformaldehyde-ﬁxed tissues were subjected to an overnight
(O/N) incubation in 70% ethanol, followed by a 4-hour in-
cubation in 95% ethanol and a ﬁnal O/N incubation in 100%
ethanol. After the ethanol treatments, tissues were incubated in
Histo-Clear (catalog number 38-7042; Ward’s Natural Sci-
ence, Rochester, NY) for 4 hours at room temperature. The
samples were exposed to a 1:1 ratio of wax (catalog number
470045-564; Ward’s Natural Science) and Histo-Clear for 4
hours, followed by a ﬁnal, 4-hour wax incubation. After this,
parafﬁn-embedded tissues were divided into sections using a
microtome and mounted onto glass slides.
Immunoﬂuorescence
Parafﬁn-embedded slides of Sirt1þ/þ and Sirt1/ VDL
prostates were incubated ﬁrst at 60C for 15 minutes. Tissues
were then deparafﬁnized using the following solution gradient:
xylene, 3 for 3 minutes; 100% ethanol, 3 for 3 minutes;
95% ethanol, 3 for 3 minutes; 70% ethanol, 3 for 3 mi-
nutes; and sterile double-distilled water (ddH2O), 1 for 5
minutes. Slides were microwaved in 1 Citra Antigen
Retrieval Solution (catalog number HK086-9K; BioGenex,
Fremont, CA) for 15 minutes and allowed to cool at room
temperature. After two phosphate-buffered saline (PBS)
washes (all washes throughout were 5 minutes), samples were
incubated in Dako peroxidase blocking solution (catalog
number 003715; Dako) at room temperature for 10 minutes,
followed by two PBS with Tween 20 washes and one PBS267
Di Sante et alwash. Next, samples were blocked in normal goat serum
(catalog number S-1000; Vector Laboratories, Burlingame,
CA) at room temperature for 30 minutes and washed. Samples
were then incubated for 1 hour in a working solution of mouse
on mouse (M.O.M.), a mouse IgG blocking reagent at room
temperature (catalog number BMK-2202; Vector Labora-
tories). After washing, tissues were incubated in a working
solution of M.O.M. diluent for 5 minutes and incubated in
primary antibody, anti-TP63 (catalog number 8431; Santa
Cruz Biotechnology), reconstituted in M.O.M. diluent O/N at
4C. After washes, tissues were incubated at room temperature
for 10minutes inM.O.M. biotinylated anti-mouse IgG reagent
and subsequently washed. Next, sections were incubated in
secondary antibody (catalog number A11029, Alexa Fluor
488; Invitrogen Molecular Probes, Grand Island, NY) at room
temperature for 30 minutes, followed by a ﬁnal wash. Sections
were subsequently mounted in prolong gold antifade reagent
with DAPI (catalog number P36931; Invitrogen Molecular
Probes), coverslipped, and analyzed by confocal microscopy
(Nikon Cl PLUS; Nikon, Melville, NY).
Cell Culture
Sirt1þ/þ and Sirt1/ 3T3 cells were maintained in regular
culture media (Dulbecco’s modiﬁed Eagle’s medium) sup-
plemented with 10% FBS, 2 mmol/L L glutamine, 100 U/
mL penicillin, and 100 mg/mL streptomycin in humidiﬁed
atmosphere containing 5% CO2 at 37C.
Electroporation
Sirt1þ/þ and Sirt1/ 3T3 cells (1  106) were transfected
by electroporation (Nucleofector 2b Device, Program NIH
3T3 U-030; Lonza, Allendale, NJ) with the expression
vectors pDsRed2-MITO (catalog number 632421; Clontech,
Mountain View, CA) and 23955 YFP-PARK2 (catalog
number 23955; Addgene, Cambridge, MA). Analysis was
conducted by confocal (Nikon Cl PLUS) and live (Zeiss
Axiovert Zoom; Zeiss, Dublin, CA) microscopy.
Live Imaging
The Sirt1þ/þ and Sirt1/ 3T3 cells were electroporated
with expression plasmid DNA and seeded onto 6-cm tissue
culture plates for live imaging (P35G-1.5-14C; MatTek
Corporation, Ashland, MA). The cells were allowed to
recover for 12 hours in cell culture media, after which the
regular medium was replaced with Dulbecco’s modiﬁed Ea-
gle’s medium phenol-free medium supplemented with 10%
FBS, 2 mmol/L L glutamine, 100 U/mL penicillin, and 100
mg/mL streptomycin. The cells were analyzed by live mi-
croscopy for 4 hours in the presence of 1 mmol/L carbonyl
cyanide 4-(triﬂuoromethoxy) phenylhydrazone (FCCP; cata-
log number C2920; Sigma-Aldrich, St. Louis, MO), an un-
coupler of mitochondrial oxidative phosphorylation. The
recruitment of Park2 was quantitated by calculating the area268of each Park2 aggregate within the cell using ImageJ software
version 1.48a (NIH, Bethesda, MD).
ROS Detection
Cellular ROS was measured by a ﬂuorogenic probe (catalog
number C10422; Invitrogen Molecular Probes). The cell-
permeable dye is non-ﬂuorescent while in a reduced state,
and exhibits bright ﬂuorescence on oxidation by ROS.
H2DCFDA at 5 mmol/L was used to stain the cells for 30
minutes, followed by ﬂuorescence-activated cell sorting of
stained cells at excitation and emission wavelengths of 492 to
495 and 517 to 527mm, respectively. H2DCFDA ﬂuorescence
is induced on removal of the acetate group on oxidation-
induced activation of intracellular esterases. Cellular ﬂuores-
cent intensity was analyzed by ﬂuorescence-activated cell
sorting. The quantitated ﬂuorescent signal was compared be-
tween the two cell lines and in the presence of ROS inhibitors,
as previously described30: 5 mmol/L N-acetyl-L-cysteine
(NAC; catalog number A9165; Sigma-Aldrich), 10 mmol/L
ammonium pyrrolidinedithiocarbamate (PDTC; P8765;
Sigma-Aldrich), and 5 mmol/L rotenone (catalog number
R8875; Sigma-Aldrich). Hydrogen peroxide (50 mmol/L; cat-
alog number P170-500; Fisher Scientiﬁc, Pittsburgh, PA) was
used to enhance ROS production in 3T3 Sirt1þ/þ cells.30
Western Blot Analysis
Whole-cell lysates (50 mg) were separated by 10% SDS-PAGE
gel, and the proteins were transferred to nitrocellulose mem-
brane for Western blot analysis, as previously described,31 and
probed for SIRT1 (catalog number 15404; Santa Cruz
Biotechnology), SOD2-AcK68 (provided byDr.DavidGius29),
and b-tubulin (catalog number T4026; Sigma-Aldrich).
SOD2 Activity Assay
All assayswereperformed in triplicate, according toBeauchamp
and Fridovich.32 According to this assay, the proportion of
active enzyme is directly proportional to the intensity of the
bands.Sirt1þ/þ andSirt1/ 3T3cells (1.2 106)wereplated in
a 10-cm plate for 36 hours before protein lysis. Cells were
washed three times with PBS not containing Ca2þ or Mg2þ.
Then, 200mLof native lysis buffer (2.7mmol/LKCl, 1.5mmol/
LH2PO4, 8mmol/LNaHPO4, and 136.9mmol/LNaCl, pH7.0)
was applied to the plate. Cells were harvested and sonicated
using a Diagenode Bioruptor (Diagenode, Denville, NJ) on the
high setting for 5 minutes, divided into 30-second on/off in-
tervals. Lysates were then centrifuged using a tabletop centri-
fuge at 12,000  g for 5 minutes at 4C. The supernatant was
then transferred to a new collection 1.5-mL tube. Proteins were
quantiﬁed using the BioRad Protein Assay, according to their
speciﬁcations (catalog number 500-0006; Bio-Rad, Hercules,
CA), and electrophoresed on a 12% stacking gel.
Once 12% native gel was polymerized, it was run in pre-
electrophoresis buffer (for 1 L; 22.76 g of Tris and 0.38 g ofajp.amjpathol.org - The American Journal of Pathology
Figure 1 Sirt1/ mice show prostatic intraepithelial neoplasia (PIN) in prostate gland at 7 months. A: H&E and IHC staining of both anterior (AP) and
ventro-dorsolateral (VDL) prostates in Sirt1þ/þ and Sirt1/ mice. H&E staining demonstrates presence of a focal atypical intraductal proliferation in Sirt1/
mouse prostate, compatible with PIN. The boxes represent areas considered for digital zoom magniﬁcation. a-Methylacyl-CoA racemase (AMACR) and Ki-67
immunostaining of both AP and VDL prostate in Sirt1þ/þ and Sirt1/ mice. BeE: Quantitation of AMACR immunoreactivity in Sirt1þ/þ and Sirt1/ AP
(PZ 0.012) and VDL prostate (PZ 0.045). Ki-67eimmunoreactive cells in Sirt1þ/þ and Sirt1/ AP (PZ 0.004) and VDL (PZ 0.016) prostate. A Student’s
t-test was performed on all comparisons. Whole data are shown as means  SEM. n Z 3 separate mice. *P < 0.05, **P < 0.01.
SIRT1 Governs SOD2, PARK2, and MitophagydisodiumEDTA in 980mLof ddH2O, pH to 8.8 and bring up to
1 L). Protein lysates (250 mg) were loaded in each lane, then run
at 100 V for approximately 1 hour or until the samples were
completely inside the stacking gel. Once they had entered the
stacking gel, the pre-electrophoresis buffer was discarded andThe American Journal of Pathology - ajp.amjpathol.orgfresh/cold electrophoresis buffer (for 1 L; 6.06 g of Tris, 22.50 g
of glycine, and 0.68 g of disodiumEDTA)was added to 960mL
of ddH2O, pH to 8.3, and brought up to 1 L. The gel was then
run at 100V until the dye had reached the end of the gel. Once it
had reached the end of the gel, it was run for another hour.269
Figure 2 Sirt1/ mice show a switch in the
autophagy from 3- to 7-month-old prostates. A and
B: Becn1 immunostaining of anterior prostate (AP)
in Sirt1þ/þ and Sirt1/ mice aged 3 months and
quantitation of immunoreactivity (P Z 0.0075).
C and D: Becn1 immunostaining of AP in Sirt1þ/þ
and Sirt1/ mice aged 7 months and quantitation
of immunoreactivity (P Z 0.008). EeH: IHC
staining for Becn1 in the stromal ﬁbroblasts (red
arrows) and epithelial cells (black arrows) in
7-month-old Sirt1þ/þ and Sirt1/ AP and ventro-
dorsolateral (VDL) prostates. Quantitation of
Becn1 immunoreactivity in AP (PZ 0.023) and VDL
(PZ 0.036) prostates. A Student’s t-test was per-
formed on all comparisons. Whole data are shown as
means  SEM (n Z 3 separate mice). *P < 0.05,
**P < 0.01.
Di Sante et alThe gel was removed from the electrophoresis apparatus and
placed into a plastic container. The SOD2 stain (25 mg of Nitro
Blue tetrazolium, 85 mL of tetramethylethylenediamine, 10 mg
riboﬂavin-50-phosphate, and 0.7 mg NaCNwere dissolved in 50
mL of ddH2O) was applied to the gel and set to shake at room
temperature in the dark for 20 minutes. After shaking, ddH2O
was used to wash the gel twice; then, the gel was placed under a
ﬂuorescent light untilwhite bands could be seen against the blue/
purple background. By using a Perfection V750 PRO scanner
(Epson,LongBeach,CA), pictureswere takenof the stainedgel.
Analysis of the scanned gels was performed using ImageJ.
Tissue Oxidative Stress Detection
Tissue oxidative stress was detected using OxyIHC Oxidative
Stress Detection Kit (catalog number S7450; Millipore, Bill-
erica, MA). Parafﬁn-embedded prostate slides were deparafﬁ-
nized and rehydrated [xylene, 2 minutes; xylene 1:1 with 100%
ethanol, 3 minutes; 100% ethanol, 2 minutes; 95% ethanol,2703 minutes; 70% ethanol, 3 minutes; 50% ethanol, 3 minutes;
Ultra Pure H2O (catalog number D4641; Thermo Fisher Sci-
entiﬁc, Waltham, MA)]. Antigen unmasking was performed
adding 1 antigen retrieval buffer (20minutes at 100C). After
three washes using 1 wash buffer (5 minutes each), dini-
trophenylhydrazine solution was added (30 minutes at room
temperature). After dinitrophenylhydrazine incubation, three
washes were applied with 1 wash buffer (5 minutes each),
and the unspeciﬁc antigens were covered with 1 blocking
buffer (20 minutes at room temperature). The primary antibody
was incubated on the slides in a humidiﬁed chamber O/N at
4C. The slides were washed with 1 wash buffer (3 for 5
minutes) and incubated with a biotinylated secondary antibody
(30 minutes at room temperature). After three washes using 1
wash buffer (5 minutes each), quenching was performed by
incubating the slides with 3% H2O2 for 10 minutes at room
temperature. The 3% H2O2 solution was removed with three
1 wash buffer washes (5 minutes each), and the slides were
incubated with streptavidin-conjugated horseradish peroxidaseajp.amjpathol.org - The American Journal of Pathology
Figure 3 Induction ofmitophagy at 7months in prostate of Sirt1/mice.A: IHC staining of Nip3-like protein X (Bnip3l) and light cycle (LC)-3 in anterior (AP) and
ventro-dorsolateral (VDL) prostates for Sirt1þ/þ and Sirt1/mice. B and C: Quantitation of Bnip3l immunoreactivity in Sirt1þ/þ and Sirt1/ AP (P< 0.001) and VDL
(PZ 0.013) prostate gland. D and E: Quantitation of LC-3 immunoreactivity in Sirt1þ/þ and Sirt1/ AP (PZ 0.016) and VDL (PZ 0.017) prostate. F and H: High
magniﬁcation of the Bnip3l IHC staining in AP and VDL prostates for 7-month-old Sirt1þ/þ and Sirt1/ mice (red arrows, ﬁbroblasts; black arrows, epithelial cells).
G and I: Quantitation of Bnip3l immunoreactivity in the stromal ﬁbroblasts and epithelial cells of Sirt1þ/þ and Sirt1/ AP and VDL prostate (PZ 0.040). A Student’s
t-test was performed on all comparisons. Whole data are shown as means SEM. nZ 3 separate mice. *P< 0.05, ***P< 0.001.
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Figure 4 Induction of Trp63 and phospho-50-
adenosine monophosphate-activated protein ki-
nase (pAMPK) in Sirt1/ prostatic intraepithelial
neoplasia (PIN) lesions. A: Trp63 (green) immu-
nostaining of Sirt1þ/þ and Sirt1/ mouse ventro-
dorsolateral (VDL) prostates. The nuclei were
stained with DAPI (blue). B: Quantitation of Trp63
immunoreactivity in Sirt1þ/þ and Sirt1/ VDL
prostate (P < 0.001). C: pAMPK immunostaining
of anterior prostate (AP) in 7-month-old Sirt1þ/þ
and Sirt1/ mice. D: Quantitation of pAMPK
immunoreactivity in 7-month-old Sirt1þ/þ and
Sirt1/ AP (P Z 0.020). E: pAMPK immuno-
staining of VDL prostate in 7-month-old Sirt1þ/þ
and Sirt1/ mice. F: Quantitation of pAMPK
immunoreactivity in 7-month-old Sirt1þ/þ and
Sirt1/ VDL prostate (P Z 0.002). A Student’s
t-test was performed on all comparisons. Whole
data are shown as means  SEM. n Z 3 separate
mice. *P < 0.05, **P < 0.01, and ***P < 0.001.
Di Sante et al(30 minutes at room temperature). After the washes, the slides
were incubated with 3,30-diaminobenzidene [DAB A (cata-
log number CS205113, Millipore) and DAB B (catalog
number CS205109, Millipore)] mixture solution and Ultra
Pure H2O (Thermo Fischer Scientiﬁc) was used to stop the
reaction. After the 3,30-diaminobenzidene reaction, the slides
were dehydrated (ethanol 100%, 2 for 5 minutes) and
washed with xylene (3 for 5 minutes). Mounting medium
was added to the samples, and the slides were covered with a
plastic slip. The slides were allowed to dry O/N and visual-
ized on a light microscope (Nikon Eclipse 50i).
Statistical Analysis
The statistical analysis was performed using Prism version 4
(GraphPad Software, San Diego, CA). P < 0.05 was
considered statistically signiﬁcant.
Results
Reduced SIRT1 Expression in Poor Prognosis PCa
To determine the predictive value and the biological signiﬁ-
cance of altered SIRT1 expression in human PCa samples, 154272patient samples were examined. The relative expression
of SIRT1 was reduced in patients with poor prognosis
(Supplemental Figure S1A) (82% versus 67%; PZ 0.012). To
determine the subcellular compartmentalization and cell type in
which SIRT1 was expressed, human PCa and normal prostate
tissue were double stained with SIRT1 and either cytokeratin
5 (KRT5; a basal epithelial cell marker) (Supplemental
Figure S1B) or cytokeratin 8 (KRT8; a luminal epithelial cell
marker) (Supplemental Figure S1C). KRT5-positive cells
showed an increased abundance of nuclear SIRT1 in PCa tis-
sues (P < 0.001) (Supplemental Figure S1D). KRT8-positive
cells showed an increased abundance of cytoplasmic SIRT1
in PCa tissues (PZ 0.019) (Supplemental Figure S1E).Sirt1/ Mice Develop PIN and Show an Increased
AMACR and Ki-67 Staining
To determine the role of Sirt1 in the development of murine
prostate PIN and autophagy, Sirt1þ/þ and Sirt1/ mice were
examined at 7 months. On the basis of H&E staining, Sirt1/
mice showed morphological changes characteristic of PIN,
including a larger stromal layer with increased cellularity and
nuclear atypia in both AP and VDL prostate (Figure 1A andajp.amjpathol.org - The American Journal of Pathology
Figure 5 Seven-month-old prostate tissues and 3T3 Sirt1/ cells show an increase of endogenous reactive oxygen species (ROS) production.A: IHC staining for
oxidized proteins in 3- and 7-month-old Sirt1þ/þ and Sirt1/ prostates. BeE: Quantitation of oxidized protein staining for 3-month-old mice anterior prostate
(AP), ventro-dorsolateral (VDL), 7-month-old mice AP, and VDL. F: Fluorescence intensity spectrum for endogenous ROS measurement in unstained (magenta), 3T3
Sirt1þ/þ (blue), and Sirt1/ (red) cells. Endogenous ROS production is higher in Sirt1/ 3T3 cells (P < 0.003). G: ROS production was measured in 3T3 Sirt1þ/þ
cells in the presence of ROS inducer hydrogen peroxide (P Z 0.001). H: ROS production was measured in 3T3 Sirt1/ cells in the presence of ROS inhibitors:
rotenone (Rot), NAC, and PDTC (P< 0.001, PZ 0.006, and PZ 0.010, respectively). A Student’s t-test was performed on all comparisons. Whole data are shown as
means  SEM. nZ 3 separate experiments. *P < 0.05, **P < 0.01, and ***P < 0.001.
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Di Sante et alSupplemental Figure S2). AMACR and Ki-67 expression is
highly correlated with PIN.33 IHC staining for AMACR and
Ki-67 (Figure 1A and Supplemental Figure S2) was con-
ducted on both the AP and VDL prostate. The AMACR
abundance was increased fourfold in AP (P Z 0.012)
(Figure 1B) and approximately twofold in VDL prostate of
Sirt1/ mice (P Z 0.045) (Figure 1C). The number of Ki-
67epositive cells was increased approximately threefold in
the Sirt1/ AP (PZ 0.004) (Figure 1D) and approximately
ﬁvefold in the Sirt1/ VDL (P Z 0.016) (Figure 1E)
prostate.
Sirt1 Switch to Inhibitor of Mitophagy in Prostate
Tissues in Vivo and Sirt1/ PIN Lesions Are Associated
with Stromal Fibroblast Mitophagy
Because mitophagy can contribute to cellular stress resis-
tance and thereby promote cellular growth,19,34 we consid-
ered the possibility that increased mitophagy may have
contributed to the ongoing increased growth of the Sirt1/
prostate. To determine whether ongoing cellular stress in the
prostate of Sirt1/ mice may have induced autophagy, we
compared the prostate of 3- and 7-month-old Sirt1þ/þ versus
Sirt1/ mice. IHC staining for Becn1 on the histological
prostate sections of 3- and 7-month-old mice demonstrated an
increase in Becn1 in the 7-month-old Sirt1/ prostates
(Figure 2, AeD). The 3-month-old Sirt1þ/þmice showBecn1
abundance increased in the AP compared with the Sirt1/
mice (Figure 2A and Supplemental Figure S3A), with a rela-
tive abundance increased approximately threefold
(PZ 0.0075) (Figure 2B). The 7-month-old Sirt1/mice
show a Becn1 abundance higher in the AP (Figure 2C and
Supplemental Figure S3A), by more than twofold
(Figure 2D) (PZ 0.008). Tumor progression is associated
with the induction of autophagy in the tumor stroma,
providing micronutrients to the tumor epithelial cells.35 To
determine whether mitophagy was occurring in the stroma
associated with the PIN lesions, quantitative IHC was
conducted. Becn1 immunoreactivity was increased three-
fold in the Sirt1/ stromal ﬁbroblasts in the AP prostate
(Figure 2, E and F, and Supplemental Figure S3B) and
10-fold in the VDL prostate (Figure 2, G and H, and
Supplemental Figure S3B), associated with PIN. Becn1
IHC staining was also increased in the epithelial cells of the
AP (Figure 2, E and F, and Supplemental Figure S3B) and
VDL (Figure 2, G and H, and Supplemental Figure S3B).
At 7 months, the Bnip3l and LC-3 abundance in both Sirt1/
AP and VDL prostate cells was increased compared with
Sirt1þ/þ cells (Figure 3A and Supplemental Figure S4A). The
relative abundance of both autophagic markers was increased
in both Sirt1/ AP and VDL (P < 0.001, P Z 0.013,
P Z 0.016, and P Z 0.017, respectively) (Figure 3, BeE).
Only minor changes in Bnip3l abundance were observed in
Sirt1/ ﬁbroblasts (Figure 3, F and G, and Supplemental
Figure S4B). Bnip3l abundance was increased in the VDL
epithelial cells (P Z 0.040) (Figure 3, H and I, and274Supplemental Figure S4B). The inducing of Becn1
immunoreactivity at 7 months, indicative of mitophagy,
contrasts with the ﬁnding at 3 months, in which Becn1 IHC
was reduced in the Sirt1/ prostate (Figure 2A and
Supplemental Figure S3A).10
Bnip3l localizes to the mitochondria to participate in
mitophagy. We determined the relative colocalization of
Bnip3l in Sirt1þ/þ versus Sirt1/ 3T3 cells. Bnip3l showed
enhanced mitochondrial colocalization in Sirt1/ 3T3 cells
(Supplemental Figure S4C). Thus, Sirt1 inhibits expression
of the mitophagy marker, Becn1, and inhibits Bnip3l
recruitment to mitochondria.
Trp63 and pAMPK Are Overexpressed in Sirt1/ Mice
Prostates
The TP63 protein is a homologue of TP53, which is highly
expressed in basal prostate cells.36 Immunoﬂuorescence
staining for Trp63 was conducted on the VDL prostate
(Figure 4A). The Trp63 abundance in the Sirt1/ prostate
cells was increased approximately fourfold compared with
littermate controls (P < 0.001) (Figure 4B). Recent studies
have demonstrated induction of pAMPK in PIN.37 IHC
for pAMPK was increased in the Sirt1/ compared with
Sirt1þ/þ AP (P Z 0.020) (Figure 4, C and D, and
Supplemental Figure S5) and VDL (PZ 0.002) (Figure 4, E
and F, and Supplemental Figure S5).
Sirt1 Inhibits ROS Production and Induces Sod2
Activity
We determined the oxidative stress to Sirt1þ/þ and Sirt1/
prostate tissues using the OxyIHC Oxidative Stress Detection
Kit. At 3 months of age, Sirt1þ/þ mice show a greater basal
oxidation than Sirt1/mice in both AP (P< 0.001) and VDL
Sirt1þ/þ prostates (Figure 5, AeC, and Supplemental
Figure S6). However, at 7 months of age, Sirt1/ mice
showed a greater basal oxidative stress in both the AP
(P < 0.001) and VDL (PZ 0.013). Thus, with age, there is a
relatively greater increase in oxidative stress in Sirt1/
prostates (Figure 5, A, D, and E, and Supplemental Figure S6).
Wenext determinedROSproduction inSirt1þ/þ andSirt1/
3T3 cells using a ﬂuorogenic dye that exhibits ﬂuorescence on
oxidation by ROS. ROS production was increased 2.5-fold in
Sirt1/ 3T3 cells (P Z 0.003) (Figure 5F). Hydrogen
peroxideeinduced ROS production approximately twofold in
Sirt1þ/þ 3T3 cells (P Z 0.001) (Figure 5G). To conﬁrm the
validity of these assays, well-characterized ROS inhibitors were
used. ROS production in Sirt1/ 3T3 cells was reduced by
rotenone, NAC, or PDTC (P Z 0.001, P Z 0.006, and
PZ 0.010, respectively) (Figure 5H).
SOD2 serves as a key detoxifying enzyme of ROS pro-
duction. We, therefore, conducted Sod2 activity assays on
Sirt1/ versus Sirt1þ/þ ﬁbroblasts (Figure 6A). Sod2
activity was reduced in Sirt1/ ﬁbroblasts (P < 0.001)
(Figure 6B). To determine whether the reduction in Sod2ajp.amjpathol.org - The American Journal of Pathology
Figure 6 Sirt1/ cells show a reduced superoxide dismutase 2 (Sod2) activity. A: Sod2 activity detection in 3T3 Sirt1þ/þ and Sirt1/ cells in presence
and absence of ethanol. B: Sod2 activity quantiﬁcation on the basis of band intensity (P < 0.001). C: Western blot analysis probed for anti-SIRT1, antieSOD2-
AcK68, and b-tubulin (as loading control). D: Densitometric analysis of SOD2-AcK68 (P < 0.001). EeH: Oncomine cancer-proﬁling database analysis of SOD2
expression in PCa versus normal tissue. Using the Tomlins database, SOD2 is down-regulated in benign prostatic hyperplasia (P < 0.001, fold
changeZ 3.19), PIN (P < 0.001, fold changeZ 4.24), and prostate adenocarcinoma (PZ 0.047, fold changeZ 2.06). Using the Tomlins database,
SIRT1 is down-regulated in benign prostatic hyperplasia (PZ 0.015, fold changeZ 1.547). Using the Wallace database, SOD2 is down-regulated in prostate
adenocarcinoma (P < 0.001, fold change Z 1.965). Using the Wallace database, SIRT1 is down-regulated in prostate adenocarcinoma (P Z 0.015, fold
changeZ 1.10). The black circles in EeH represent outliers. ***P < 0.001. BPH, benign prostatic hyperplasia; NPG, normal prostate gland; PC, prostate
adenocarcinoma; and PIN, prostatic intraepithelial neoplasia.
SIRT1 Governs SOD2, PARK2, and Mitophagyactivity in Sirt1/ cells was due to reduced Sod2 abun-
dance, we determined Sod2 mRNA and protein and pro-
moter regulation by Sirt1. Sod2 expression is induced by
ROS and is repressed by endogenous apoptosis-inducing
genes, including Jun,30 E2f1, and Myc.38 In contrast with
the increased Sod2 activity in Sirt1þ/þ ﬁbroblasts, Sod2The American Journal of Pathology - ajp.amjpathol.orgmRNA, protein, and promoter activity were repressed by
Sirt1 (data not shown). Sod2 activity and the ability to
scavenge ROS are inhibited by acetylation.39 We, therefore,
considered that SIRT1 may regulate SOD2 activity through
post-transcriptional mechanisms. SOD2 is acetylated by
histone acetyltransferase, p300, and P300/CBP-associated275
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276factor. Sod2 acetylation Western blot analysis was con-
ducted using antieSOD-AcK68 antibody. A substantial
increase in Sod2 acetylation was observed in the Sirt1/
ﬁbroblasts (P < 0.001) (Figure 6, C and D).
By using Oncomine, a cancer-proﬁling database, we
compared both SOD2 and SIRT1 expression in different
stages of human PCa versus normal tissue reported in two
databases: Tomlins and Wallace. By using the Tomlins data-
base, SOD2 (Figure 6E) and SIRT1 (Figure 6F) were down-
regulated in benign prostatic hyperplasia (P < 0.001, fold
change Z 3.19, and P Z 0.015, fold change Z 1.547,
respectively), SOD2 was also down-regulated in PIN
(P < 0.001, fold changeZ 4.24) and prostate adenocarci-
noma (P Z 0.047, fold change Z 2.06) (Figure 6E). By
using the Wallace database, SOD2 (Figure 6G) and SIRT1
(Figure 6H) were down-regulated in prostate adenocarcinoma
(P < 0.001, fold change Z 1.965, and P Z 0.039, fold
changeZ 1.10, respectively).
Sirt1 Inhibits Park2 Translocation to Mitochondria
To determine whether Sirt1 inhibition of mitophagy may
involve the inhibition of Park2 recruitment, mitochondria of
3T3 Sirt1þ/þ and Sirt1/ cells were monitored by live mi-
croscopy. FCCP induces transient mitochondrial
depolarization and recruitment of Park2. FCCP administration
(0 minutes) induced Park2 recruitment in 3T3 Sirt1þ/þ versus
Sirt1/ cells (55 minutes) (Figure 7, A and B). Park2
recruitment kinetics were monitored for 15 minutes at an in-
terval of 5minutes (60, 65, and 70minutes) (Figure 7C). Park2
aggregate areas were quantitated. At 70 minutes, the recruit-
ment of Park2 was signiﬁcantly increased in Sirt1/ cells
(PZ 0.039) (Figure 7C). Together, these studies are consis-
tent with a model in which SIRT1 deacetylation of SOD2
induces SOD2 activity and reduces ROS production, PARK2
recruitment, and autophagy. The induction of autophagy in the
local stress of the PIN lesions in Sirt1/ mice may provide
key micronutrients known to promote aberrant epithelial cell
growth.
Discussion
Herein, deletion of Sirt1 induced PIN in 7-month-old mice, as
evidenced by histological features of increased cellularity andFigure 7 Time lapse of Park2 recruitment during the mitophagy pro-
cess in Sirt1/ 3T3 cells. A: Park2 (green) translocation into the mito-
chondria (red) was monitored by live microscopy in Sirt1/ cells after 1
mmol/L FCCP administration. Starting from FCCP administration (0 mi-
nutes), Park2 and mitochondrial signals were detected every 5 minutes.
Park2 recruitment started at 55 minutes. The maximum recruitment of
Park2 occurs in a frame of time lasting 15 minutes. B: Magniﬁcation of
Park2 and mitochondria colocalization (arrows) at 70 minutes after phe-
nylhydrazone (FCCP) administration. C: Quantitation of Park2 recruitment
in 3T3 Sirt1þ/þ (black circles) and Sirt1/ (black triangles) cells at 60, 65,
and 70 minutes (P Z 0.039). A one-way analysis of variance was per-
formed for the statistical analysis. Data are shown as means  SEM. nZ 5.
*P < 0.05.
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SIRT1 Governs SOD2, PARK2, and Mitophagynuclear atypia, glandular hyperplasia, and increased staining
for Ki-67, Trp63, and AMACR in Sirt1/ mice.10 First, the
current ﬁndings extend prior studies that suggested that PIN
occurs in 3-month-old Sirt1/ mice prostates on the basis of
H&E staining10 through the use of AMACR and Trp63
staining. Second, these studies demonstrate that PIN persists at
7 months in Sirt1/ mice. Third, these studies demonstrate
mitophagy in both the epithelial and ﬁbroblast compartment of
the prostate in Sirt1/ mice. Fourth, these studies demon-
strate an increase in intracellular oxidative stress in the
Sirt1/ prostate.
The role of SIRT1 as either an oncogene or a tumor sup-
pressor may be cell-type speciﬁc; however, it is still contro-
versial. The following studies have shown that SIRT1may have
an oncogenic role in advanced PCa. Huffman et al40 have
demonstrated that Sirt1/SIRT1 is overexpressed in the mouse
model and advanced human PCa, and it was also found to
promote PCa cell growth and survival.41 Yang et al42 have also
demonstrated that the tumor-suppressor activity of forkhead
boxO 1 is suppressed by SIRT1-mediated deacetylation in PCa
cells, and Wang et al43 have found that SIRT1 is a key down-
stream effector of nicotinamide phosphoribosyltransferase for
oxidative stress in prostate cancer. An overexpression of nico-
tinamide phosphoribosyltransferase in PCa cells along with
SIRT1 leads to oxidative stress resistance.43 Moreover, SIRT1
promotes both cell invasion in PCa cells enhancing matrix
metalloproteinase-2, which has been shown to play an impor-
tant role in cancer cell invasion,44 and induction of epithelial-
to-mesenchymal transition through the promotion of the
transcription factor ZEB1.45 However, the current studies
demonstrate reduced SIRT1 levels in patients with PCa are
associatedwith reduced recurrence-free survival in human PCa.
Consistentwith the current studies inwhichSIRT1 inhibits PIN,
SIRT1 suppressed intestinal tumorigenesis in colon cancer.46 In
these prior studies, SIRT1 deacetylatedb-catenin and promoted
cytoplasmic localization of b-catenin.46 The reintroduction of
SIRT1 into TP53 mutant cancer cells suppresses tumor for-
mation, likely related to a role of SIRT1 in DNA damage
repair.47 In PCa cells, SIRT1 was shown to inhibit AR activity
and cellular proliferation.9 The ability of SIRT1 to inhibit PCa
cell proliferation in tissue culture involved the catalytic domain
and correlated with AR deacetylation. The inhibition of AR
expression and activity by SIRT1 is likely mediated in part
through deacetylation of the AR.9,48e50
The current studies demonstrated increased cytoplasmatic
SIRT1 in luminal cell prostate. Herein, endogenous Sirt1
inhibited mitophagy in the prostate of mice. The key autophagy
proteins BECN1 and, in yeast, autophagy-related protein 5
(Atg5) or Atg9p are localized in mitochondria.51e53 Atg5 and
microtubule-associated protein LC-3 localize to punctae on
mitochondria.54 The BNIP3L is an important regulator of
mitophagy55,56 and is primarily integrated into the mitochon-
drial membrane, and BNIP3L overexpression leads to loss of
membrane potential and cell death. BECN1,BNIP3L, andLC-3
are important for the removal of mitochondria during the
autophagic response.56 The relative abundance of theThe American Journal of Pathology - ajp.amjpathol.orgmitophagy markers Bnip3l, Becn1, and LC-3 was increased in
the Sirt1/ prostate epithelium. Careful analysis of autophagy
markers in the epithelial cells and the stroma of the Sirt1/ PIN
lesions evidenced both epithelial cells and stroma ﬁbroblast
mitophagy.57 Herein, Bnip3l showed enhanced mitochondria
localization in Sirt1/ ﬁbroblasts. Cells remove damaged
mitochondria to prevent the accumulation of ROS. Mitochon-
drial autophagy or mitophagy is a process of mitochondrial
quality control. ROS, including superoxide anions, are by-
products of oxidative phosphorylation and are eliminated
by the scavenger enzyme, Sod2, which converts superoxide
anions to hydrogen peroxide.38 The PARK2 protein is
recruited in a ROS-dependent manner to mitochondria
binding to PTEN-induced putative kinase 1 and inducing
mitophagy of depolarizedmitochondria.58Mitophagy allows
for the selective removal of dysfunctional mitochondria by
autophagosomes. Mitophagy may occur in a PARK2-
dependent or PARK2-independent manner.
The induction of stroma ﬁbroblast mitophagy has been
proposed as a mechanism promoting the turnover of proteins,
and the PIN lesions may be supported through the production
of micronutrients released from the mitophagic microenvi-
ronment. The current studies demonstrate a shift from the 3- to
7-month PIN lesions in which Sirt1 induced autophagy at 3
months and inhibited autophagy at 7 months. SIRT1 has been
shown to both inhibit and induce autophagy.59 What might
explain the shift toward increased mitophagy in PIN lesions
from 3 to 7 months? One explanation may be the progressive
increase in ROS production, as evidenced by tissue oxidative
stress detection (Figure 5, AeE).
Herein, Sirt1 inhibited ROS production and induced Sod2
activity. ROS are induced by oncogene stimuli (Ras and
ErbB2), and the induction of ROS may be due to the pro-
gressive reduction in SOD2 activity due to altered SOD2
acetylation status. Because Sirt1 is cytoplasmic and Sod2 is
mitochondrial, the induction of Sod2 activity and reduction
in Sod2 acetylation at lysine 68 in the Sirt1þ/þ compared
with Sirt1/ may have been indirect because of the in-
crease in mitochondrial Sirt3 (data not shown).
How might the induction of mitophagy in the Sirt1/
prostate contribute to PIN? The induction of autophagy has
been shown to promote tumor progression in the context of
Myc-dependent tumor growth.34 AMPK promotes cancer cell
survival in the presence of stressors, whether bioenergetics,
growth factor, or oncogene induced. pAMPK was induced in
the prostate of the Sirt1/ mice, AMPK can function as a
context-dependent oncogene,34,60 and the induction of pAMPK
is observed in other mouse models of PIN. Thus, the pAMPK
induction may have contributed to the PIN phenotype in
Sirt1/ mice.Acknowledgments
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